Pancreas Cancer

Natural Cancer Supplement: Cell Forte with IP-6 and Inositol by Enzymatic Therapy

Wed, 13 Feb 2008 07:42:35 +0100

Cell Forte with IP-6 is a unique combination of inositol and inositol hexaphosphate (IP-6). Together, inositol and IP-6 create a remarkable increase in natural killer cell activity and enhances natural cellular defenses. Both inositol and IP-6 are found naturally in the cells of the body. However, studies show that by supplementing with Cell Forte, the cells become stronger.

Pancreas Cancer - Smaller Tumors Mean Better Chances - HealthandAge

Fri,8 Feb 2008 10:11:16 +0100

It seems pretty obvious that the smaller a tumor, the more likely it can be managed, even 'cured'. However, this hasn't been clearly demonstrated until now in the case of pancreatic cancer.

Charity prodigious with cancer survivor aid

Thu,7 Feb 2008 23:28:04 +0100

GeorgeYuhasz has turned his diagnosis of pancreatic cancer in 1999 intowhat he and others call "a labor of love." Yuhasz,who has been a special education teacher at the Middlesex County Vocational Technical High School system in East Brunswick for 30 years, formed the nonprofit group Prodigal Foundation Inc., 208 Main St.

Charity prodigious with cancer survivor aid

Tue,5 Feb 2008 23:52:43 +0100

WOODBRIDGE - George Yuhasz has turned his diagnosis of pancreatic cancer in 1999 into what he and others call "a labor of love." Yuhasz, who has been a special education teacher at the Middlesex County Vocational Technical High School system in East Brunswick for 30 years, formed the nonprofit group Prodigal Foundation Inc., 208Main St.

Immunomedics Announces Second Quarter Fiscal 2008 Results

Thu,7 Feb 2008 20:30:00 +0100

MORRIS PLAINS, N.J., Feb. 7, 2008 - Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported revenue of $1.0 million and a net loss of $3.2 million, or $0.04 per share, for the second quarter of fiscal year 2008, which ended December 31, 2007.

Saturday, February 9, 2008

Fri,8 Feb 2008 19:56:32 +0100

New study shows that grapes may slow the progression of Type I Autoimmune Diabetes.

High BMIs and Cancer - the Risk for Women - HealthandAge

Wed,6 Feb 2008 09:43:33 +0100

It's well known that overweight is associated with an increased risk of some cancers. Data from a large study in the UK throws more light on this risk in women.

Port Washington couple bears loss after loss

Fri,8 Feb 2008 04:47:09 +0100

Port Washington - When Denise and Kevin Tappa's son was killed two weeks ago, it was the hardest loss they have had to endure.

The Kington letters: Final words of a comic genius

Thu,7 Feb 2008 23:16:03 +0100

Ever the master humorist, Miles Kington kept readers laughing right up to the end. But at the time of his death last week, the 'Independent' columnist was also working on a literary farewell - a series of typically brilliant letters to his friend and agent, Gill Coleridge...

Susan Blumenthal, M.D.: World Cancer Day: A Call to Action

Mon,4 Feb 2008 15:04:03 +0100

Poverty is a carcinogen: lower education and income levels are linked to higher rates of cancer.

Finding good medical care for ferrets

Thu,7 Feb 2008 10:32:15 +0100

Veterinarian Karen Purcell of Londonderry, N.H., fell for ferrets in vet school. "I love the fact that they never grow up," she says, recalling how the slinky clowns ran around her house as she relaxed after a tough day in the classroom. "It's like having permanent kittens."

Johns Hopkins Develops Pancreas Cancer Risk Model; May Help Decide Who Should Get Early Screening.

Byline: Johns Hopkins Medical Institutions BALTIMORE, April 16- People with a family history of pancreas cancer now have a way to accurately predict their chance of carrying a gene for hereditary pancreas cancer and their lifetime risk of developing the disease. Developed by ...

Cardinal's Pancreas Cancer Confirmed

Joseph Cardinal Bernardin suffers from cancer of the pancreas, his doctors confirmed Wednesday, and although most of the malignancy was removed during surgery, his chances of long-term survival remain only one in four. Because it is highly unlikely that all microscopic cancer cells were detected ...

Ukrain (NSC-631570) in the treatment of pancreas cancer.

Ukrain (NSC-631570) in the treatment of pancreas cancer. Zemskov VS, Procopchuk OL, Susak YM, et al. Drugs Exp Clin Res 2000;26:179-190 The aim of this study was to investigate the effects of Ukrain in the treatment of pancreatic cancer. Most patients with advanced pancreas cancer experience pain ...

Active Biotech's Application to Start Phase II Pancreas Cancer Trial Approved by UK Authorities.

Business EditorsandHealth/Medical Writers LUND, SwedenBUSINESS WIREFeb. 7, 2002 Active Biotech's application for the initiation of the TTSpancreas cancer Phase II study has been approved by MCAin the UK. Active Biotech started in ...

Cancer of pancreas 'found too late' for treatment.

Cancer of pancreas 'found too late' for treatment MOST Irish people who develop pancreatic cancer are diagnosed too late to receive any treatment. Instead, they were getting palliative care to allow them cope with the final stages of the disease, a conference in Dublin was told yesterday. Prof ...

Cancer of the pancreas

Cancer of the pancreas The pancreas is a small organ, about 6 inches long, in the upper abdomen. It is connected to the small intestine. It produces enzymes that help digest protein, fat and carbohydrates before they can be absorbed through the intestine. It also makes endocrine cells that produce ...

GlobeImmune Initiates Phase 2 Trial for Pancreas Cancer.

LOUISVILLE, Colo., June 8 /PRNewswire/ - GlobeImmune, Inc. today announced the initiation of a randomized, placebo-controlled, multi-center Phase 2 clinical trial of GI-4000, GlobeImmune's therapeutic vaccine for the treatment of patients with early-stage pancreas cancer. The primary goal of the ...

NEW HOPE OF VACCINE 'CURE' FOR CANCER; Scientists reveal treatment for pancreas disease.

Byline: ISABEL OAKESHOTT SCIENTISTS said today they are on the brink of a major cancer breakthrough with a revolutionary vaccine. The new technique has produced dramatic results against one of the most vicious cancers, that of the pancreas, which has a 95 per cent mortality rate. The findings, ...

Cancer Center at John Hopkins in Baltimore develops pancreas cancer risk model

People with a family history of pancreas cancer now have a way to accurately predict their chance of carrying a gene for hereditary pancreas cancer and their lifetime risk of developing the disease. Developed by Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center researchers, the novel ...

Apple CEO Steve Jobs' rare variety of pancreas cancer is one of most curable.

Byline: Lori Aratani Aug. 2-Pancreatic cancer can come in different - and sometimes fatal - forms, but the rare type that Apple CEO Steve Jobs announced he had been treated for is among the most curable. As Jobs wrote Sunday in his e-mail to employees, islet cell neuroendocrine tumors represent ...